Recruit Patients Faster In The Asia-Pacific Region

Asia remains one of the fastest growing regions for biotech-sponsored trials and there is a growing interest from US biotechs to expand their clinical development here. While there are many benefits in running clinical trials in Asia, sponsors can often face fragmented markets and heterogeneous regulatory pathways. This increases the need to partner with a regional CRO specialist who understands the regulatory nuances of each country to match with client-specific trial requirements.

Novotech relies on years of experience, in-country knowledge and real-life big data to identify and propose the best-performing sites and investigators for your study. Our experience span across numerous therapeutic areas and indications especially:

• Oncology CRO services, and Immuno-Oncology CRO services
• Infectious diseases and Vaccines CRO services
• Orphan and Rare diseases CRO services